Legal Representation
Attorney
Evan St John
USPTO Deadlines
Next Deadline
1553 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240430)
Due Date
April 30, 2030
Grace Period Ends
October 30, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 30, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 30, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 13, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 13, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 11, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 11, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 11, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 11, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 11, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 15, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 14, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 27, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 045
Regulatory compliance consulting in the field of pharmaceutical chemistry, manufacturing, sale, control, and risk management
First Use Anywhere:
Sep 1, 2020
First Use in Commerce:
Sep 1, 2020
Additional Information
Design Mark
The mark consists of a stylized molecule composed of three circles connected by rods in a triangle formation, and in each of the three circles are the capital letters J, P, and C, respectively. Three smaller circles, not connected by rods, sit in an overlapping triangular formation such that the three circles which do not contain letters sit in the midpoint between each circle containing a letter if a large circle were drawn to connect all of the circles. To the right of the molecule figure, the words "JORDAN PHARMA COMPLIANCE" are written in stylized and all capital letters. The word "JORDAN" is shown in larger font and stacked above the wording "PHARMA COMPLIANCE". A vertical line segment divides the molecule figure from the "JORDAN PHARMA COMPLIANCE" text" in which the molecule figure design is on the left of the vertical line and the wording "JORDAN PHARMA COMPLIANCE" is to the right of the line.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA COMPLIANCE"